Carbone Cancer Center / University of Wisconsin — Madison, Wisconsin

Carbone Cancer Center / University of Wisconsin is a clinical research site located in Madison, Wisconsin, United States United States.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Carbone Cancer Center / University of Wisconsin has participated in 8 clinical trials with 1 currently active.

Therapeutic areas: Non-Hodgkin Lymphoma, DLBCL, Diffuse Large B-cell Lymphoma.

Sponsors: Seagen Inc., Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carbone Cancer Center / University of Wisconsin?

Carbone Cancer Center / University of Wisconsin has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carbone Cancer Center / University of Wisconsin conducted?

Carbone Cancer Center / University of Wisconsin has 8 clinical trials on record, with 1 currently active. Their work covers Non-Hodgkin Lymphoma, DLBCL, Diffuse Large B-cell Lymphoma.

Is Carbone Cancer Center / University of Wisconsin accredited by Crixeo Health?

Yes — Carbone Cancer Center / University of Wisconsin holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Carbone Cancer Center / University of Wisconsin?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.